Search for: "Elan Pharmaceuticals Inc"
Results 21 - 40
of 55
Sort by Relevance
|
Sort by Date
12 Jun 2011, 9:17 pm
• Defendants: IntelliPharmaCeutics Corp.; IntelliPharmaCeutics Ltd.; Par Pharmaceutical Inc. [read post]
19 May 2011, 9:12 pm
Elan Pharmaceutical Research Corp., we considered an analogous situation in a different procedural posture. 212 F.3d at 1247-50... [read post]
15 May 2011, 8:55 pm
• Defendant: Teva Pharmaceuticals USA Inc. [read post]
11 Apr 2011, 7:15 pm
Elan Pharmaceuticals, 616 F.3d 1267, 1274 (Fed. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
9 Mar 2011, 3:00 am
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
17 Jan 2011, 10:17 am
The Elan Corporation's subsidiary, Elan Pharmaceuticals, INC. [read post]
20 Dec 2010, 2:34 pm
December has been a significant month in terms of False Claims Act recoveries from pharmaceutical companies.Three drug makers - Abbott Laboratories Inc., Roxane Laboratories Inc. and B. [read post]
15 Dec 2010, 11:16 pm
According to DOJ’s press release: Irish pharmaceutical manufacturer Elan Corporation PLC and its U.S. subsidiary Elan Pharmaceuticals Inc. [read post]
1 Sep 2010, 4:46 pm
Eon Labs, Inc. and Elan Pharmaceuticals, Inc. at http://www.patentlyo.com/patent/2010/08/ignoring-non-patentable-elements-while-judging-novelty.html Hyatt v. [read post]
13 Aug 2010, 12:46 pm
Elan Pharmaceuticals (2009-1437, -1438) precedential King acquired the patent rights from Elan. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
2 Aug 2010, 10:23 am
Eon Labs, Inc. and Elan Pharmaceuticals, Inc. [read post]
28 Jul 2010, 12:06 am
Teva Pharmaceuticals USA, Inc. [read post]
18 Jul 2010, 8:03 am
" Elan's US division Elan Pharmaceuticals Inc. [read post]
16 Jun 2010, 3:02 pm
Zydus Pharmaceuticals USA, Inc. et al. [read post]
17 Feb 2010, 5:10 am
USA, Inc; Eli Lilly & Co. v. [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
9 Oct 2009, 9:11 am
Infineon Technologies AG, Infineon Technologies North America Corporation (patent infringement) 10/6: Elan Pharma International Ltd. and Jazz Pharmaceuticals Inc. v. [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) Avinza (Morphine) – US: King Pharmaceuticals, Elan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Cipro (Ciprofloxacin) – US: California court rules that Bayer AG et al did not violate state antitrust law in Cipro reverse payment case (FDA Law Blog) Effexor (Venlafaxine) - Israel: Patent oppositions: should substance or procedural issues win out? [read post]
